Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Leukemia

Free Subscription 02.05.2022 3 Am J Hematol 1 Biochem Biophys Res Commun 2 Biochem Pharmacol 3 Blood 2 BMC Cancer 5 Br J Haematol 1 Cancer Res 2 Int J Hematol 1 J Biol Chem 1 J Clin Oncol 2 J Pediatr Hematol Oncol 1 J Virol 4 Leuk Lymphoma 1 Leuk Res 4 Leukemia 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. PEREZ-CARRETERO C, Hernandez-Sanchez M, Gonzalez T, Quijada-Alamo M, et al
   TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features.
   Am J Hematol. 2022 Apr 26. doi: 10.1002/ajh.26578.
   PubMed         Abstract available
   
   
2. KIM K, Konopleva M, DiNardo CD, Borthakur G, et al
   Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials.
   Am J Hematol. 2022 Apr 12. doi: 10.1002/ajh.26572.
   PubMed         Abstract available
   
   
3. MCLAUGHLIN N, Ruan G, Day CN, Harmsen WS, et al
   A population-based study of acute panmyelosis with myelofibrosis in the United States: 2004-2015.
   Am J Hematol. 2022;97:E144-E147.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

4. LIU L, Liu B, Guan G, Kang R, et al
   Cyclophosphamide-induced GPX4 degradation triggers parthanatos by activating AIFM1.
   Biochem Biophys Res Commun. 2022;606:68-74.
   PubMed         Abstract available
   
   

   
   Biochem Pharmacol

5. GUPTE A, Al-Antary ET, Edwards H, Ravindranath Y, et al
   The Paradox of Myeloid Leukemia Associated with Down Syndrome.
   Biochem Pharmacol. 2022 Apr 25:115046. doi: 10.1016/j.bcp.2022.115046.
   PubMed         Abstract available
   
   
6. ZHANG H, Song T, Wang Z, Laura Bonnette U, et al
   Bcr-Abl drives the formation of Hsp70/Bim PPI to stabilize oncogenic clients and prevent cells from undergoing apoptosis.
   Biochem Pharmacol. 2022;198:114964.
   PubMed         Abstract available
   
   

   
   Blood

7. ANTOSZEWSKI M, Fournier N, Ruiz Buendia GA, Lourenco J, et al
   Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.
   Blood. 2022;139:2483-2498.
   PubMed         Abstract available
   
   
8. CHIANG MY
   Firing up chromatin to forge T-ALL.
   Blood. 2022;139:2418-2420.
   PubMed        
   
   
9. CHEN Z, Simon-Molas H, Cretenet G, Valle-Argos B, et al
   Characterization of metabolic alterations of Chronic Lymphocytic Leukemia in the lymph node microenvironment.
   Blood. 2022 Apr 29. pii: 485126. doi: 10.1182/blood.2021013990.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. GHOBADI MZ, Emamzadeh R, Afsaneh E
    Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning.
    BMC Cancer. 2022;22:433.
    PubMed         Abstract available
    
    
11. GURU SA, Sumi MP, Mir R, Beg MMA, et al
    Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival.
    BMC Cancer. 2022;22:439.
    PubMed        
    
    

    
    Br J Haematol

12. JOBSON D, McCormack CJ, Mar V, Tam C, et al
    Impact of chronic lymphocytic leukaemia on melanoma outcomes: A retrospective case-control study.
    Br J Haematol. 2022;197:320-325.
    PubMed         Abstract available
    
    
13. TAYLOR T, Byrne J, Errico G, Clark D, et al
    Very late extramedullary relapse of acute myeloid leukaemia as prostatic myeloid sarcoma occurring 24 years post-allograft.
    Br J Haematol. 2022;197:243.
    PubMed        
    
    
14. OLIVEIRA AF, Tansini A, Toledo T, Balceiro R, et al
    
    Br J Haematol. 2022;197:339-348.
    PubMed         Abstract available
    
    
15. UJJANI C, Shadman M, Lynch RC, Tu B, et al
    The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic lymphocytic leukaemia.
    Br J Haematol. 2022;197:306-309.
    PubMed         Abstract available
    
    
16. CARTWRIGHT A, Scott S, Francis S, Whitby L, et al
    Assessing the impact of the 2017 European LeukemiaNet recommendations on FLT3 allelic ratio calculation and reporting in acute myeloid leukaemia.
    Br J Haematol. 2022;197:e35-e37.
    PubMed        
    
    

    
    Cancer Res

17. CASADO-GARCIA A, Isidro-Hernandez M, Oak N, Mayado A, et al
    Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice.
    Cancer Res. 2022;82:1098-1109.
    PubMed         Abstract available
    
    

    
    Int J Hematol

18. LU N, Lin J, Wang LL, Li YY, et al
    A retrospective single-center analysis of G-CSF-mobilized donor lymphocyte infusion in hematologic malignancies after unmanipulated allogenic PBSCT.
    Int J Hematol. 2022;115:713-727.
    PubMed         Abstract available
    
    
19. FUKUYAMA T, Kitamura T, Kozu T
    UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.
    Int J Hematol. 2022;115:686-693.
    PubMed         Abstract available
    
    

    
    J Biol Chem

20. LEE H, Sun R, Niehrs C
    Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RW(d).
    J Biol Chem. 2022;298:101586.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

21. PASQUAL E, Schonfeld S, Morton LM, Villoing D, et al
    Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies.
    J Clin Oncol. 2022;40:1439-1449.
    PubMed         Abstract available
    
    

    
    J Pediatr Hematol Oncol

22. BARR RD, Inglis D, Athale U, Farncombe T, et al
    The Influence of Body Composition on Bone Health in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: Analyses by Dual-energy X-ray Absorptiometry and Peripheral Quantitative Computed Tomography.
    J Pediatr Hematol Oncol. 2022 Apr 27. pii: 00043426-990000000-00023.
    PubMed         Abstract available
    
    
23. 
    Suspected Drug-induced Liver Injury Due to 6-Mercaptopurine With a Superimposed SARS-CoV-2 Infection in a Patient With B-ALL: Erratum.
    J Pediatr Hematol Oncol. 2022;44:193.
    PubMed        
    
    

    
    J Virol

24. ZHOU J, Zhou D, Du X, Xue J, et al
    Interaction between Avian Leukosis Virus Subgroup J Surface Protein and Doublecortin-Like Kinase 1 Accelerates Cell Proliferation and Epithelial-Mesenchymal Transition.
    J Virol. 2022;96:e0165721.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

25. LI Q, Liang C, Xu X, Zhang C, et al
    CLEC12A plays an important role in immunomodulatory function and prognostic significance of patients with acute myeloid leukemia.
    Leuk Lymphoma. 2022 Apr 23:1-13. doi: 10.1080/10428194.2022.2064986.
    PubMed         Abstract available
    
    
26. QI D, Wang J, Zhao Y, Yang Y, et al
    JMJD1C-regulated lipid synthesis contributes to the maintenance of MLL-rearranged acute myeloid leukemia.
    Leuk Lymphoma. 2022 Apr 25:1-12. doi: 10.1080/10428194.2022.2068004.
    PubMed         Abstract available
    
    
27. PHAM TM, Quy PN, Amin K, Walker E, et al
    Average lifespan shortened due to Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma, and leukemia in Japan, 1990-2015.
    Leuk Lymphoma. 2022 Apr 23:1-10. doi: 10.1080/10428194.2022.2064990.
    PubMed         Abstract available
    
    
28. MEMOLI M, Genthon A, Favale F, Lapusan S, et al
    Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study.
    Leuk Lymphoma. 2022 Apr 22:1-9. doi: 10.1080/10428194.2022.2064987.
    PubMed         Abstract available
    
    

    
    Leuk Res

29. ARORA S, Zainaldin C, Bathini S, Gupta U, et al
    Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia.
    Leuk Res. 2022;117:106844.
    PubMed         Abstract available
    
    

    
    Leukemia

30. PARDIEU B, Pasanisi J, Ling F, Dal Bello R, et al
    Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
    Leukemia. 2022 Apr 26. pii: 10.1038/s41375-022-01573.
    PubMed         Abstract available
    
    
31. JACOBY E, Ghorashian S, Vormoor B, De Moerloose B, et al
    CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study.
    Leukemia. 2022 Apr 25. pii: 10.1038/s41375-022-01546.
    PubMed         Abstract available
    
    
32. PENNESI E, Michels N, Brivio E, van der Velden VHJ, et al
    Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial.
    Leukemia. 2022 Apr 25. pii: 10.1038/s41375-022-01576.
    PubMed         Abstract available
    
    
33. STRANAHAN AW, Berezniuk I, Chakraborty S, Feller F, et al
    Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemia.
    Leukemia. 2022 Apr 23. pii: 10.1038/s41375-022-01579.
    PubMed         Abstract available
    
    

    
    PLoS One

34. MOPIN A, Lepretre F, Sebda S, Villenet C, et al
    Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity.
    PLoS One. 2022;17:e0267508.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: